Table 3.

Correlation analysis of topological parameters of anti-vegf/VEGFA complexes.

	Ranibizumab/VEGFA					Fab-bevacizumab/VEGFA					VEGFR1d2_R2d3/VEGFA
	t	adeg	asp	E	dGsolv	t	adeg	asp	E	dGsolv	t	adeg	asp	E	dGsolv
t	–	0.20	0.61	0.07	−0.12	–	−0.12	0.29	−0.20	−0.30	–	−0.60	0.35	−0.54	0.46
adeg	–	–	−0.18	0.94	−0.47	–	–	−0.13	0.91	−0.33	–	–	−0.63	0.93	−0.51
asp	–	–	–	−0.28	0.07	–	–	–	−0.17	0.05	–	–	–	−0.61	0.34
E	–	–	–	–	−0.50	–	–	–	–	−0.28	–	–	–	–	−0.45
dGsolv	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–